DUBLIN, March 30, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for Vyxeos® (daunorubicin and cytarabine) to include...
Bucher et al. A recent meta-analysis of randomized controlled trials concluded that replacing saturated fatty acids with mostly n—6 polyunsaturated fatty acids is unlikely to reduce...